Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $90.18M.
ENTERPRISE VALUE (EV)
$90.18M
Black Diamond Therapeutics, Inc.
Market Cap
$111.17M
Enterprise Value (EV)
$90.18M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $111.17M | $90.18M |
| Immunic, Inc. (IMUX)vs › | $109.93M | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.49M | $121.50M |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | $89.28M |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | $41.06M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | $107.08M |
| Genelux Corporation (GNLX)vs › | $116.59M | $109.82M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | $92.45M |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | $118.49M |
Market Cap
$111.17M
Total Debt
$0.00
Cash
$20.99M
Enterprise Value
$90.18M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
